◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › E › ECL

Ecolab Inc (ECL) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

BASIC MATERIALS · Specialty Chemicals · DATA UPDATED 2026-08-29

Ecolab Inc (ECL) operates in the Specialty Chemicals industry and is headquartered in Saint Paul, United States with about 48,000 employees. Its market capitalization is roughly $76 billion. In the fiscal year ended 2025-12-31, ECL reported $16.1B in revenue and $2.1B in net income.

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences.

Interactive charts & full statements → Open the ECL valuation workbench →

ECL Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$16.8B	$16.1B	$15.7B	$15.3B	$14.2B	$12.7B	$11.8B	$12.6B	$14.7B	$13.8B	$13.2B	$13.5B	$14.3B	$13.3B	$11.8B	$6.8B	$6.1B	$5.9B	$6.1B	$5.5B	$4.9B
Gross Profit	$7.4B	$7.2B	$6.8B	$6.2B	$5.4B	$5.2B	$4.9B	$5.5B	$6.1B	$5.8B	$6.3B	$6.4B	$6.6B	$6.1B	$5.4B	$3.4B	$3.1B	$2.9B	$3.0B	$2.8B	$2.5B
Gross Margin %	44.1%	44.5%	43.5%	40.3%	38.2%	41.0%	41.5%	44.0%	41.3%	42.1%	47.9%	47.0%	46.3%	45.7%	46.0%	49.3%	50.6%	49.6%	48.8%	50.8%	50.6%
Operating Income (EBIT)	$2.9B	$2.9B	$2.6B	$2.2B	$1.6B	$1.7B	$1.7B	$1.9B	$2.0B	$2.2B	$2.0B	$2.0B	$2.0B	$1.8B	$1.5B	$928M	$823M	$750M	$738M	$687M	$612M
Operating Margin %	17.4%	18.1%	16.6%	14.1%	11.3%	13.2%	14.5%	15.2%	13.5%	15.9%	15.3%	14.6%	14.2%	13.4%	12.9%	13.6%	13.5%	12.7%	12.0%	12.6%	12.5%
Net Income	$2.1B	$2.1B	$2.1B	$1.4B	$1.1B	$1.1B	($1.2B)	$1.6B	$1.4B	$1.5B	$1.2B	$1.0B	$1.2B	$968M	$704M	$462M	$530M	$417M	$448M	$427M	$369M
Net Margin %	12.6%	12.9%	13.4%	9.0%	7.7%	8.9%	-10.2%	12.4%	9.7%	10.9%	9.3%	7.4%	8.4%	7.3%	5.9%	6.8%	8.7%	7.1%	7.3%	7.8%	7.5%
EBITDA	$3.3B	$3.5B	$3.8B	$3.0B	$2.5B	$2.5B	$2.2B	$2.7B	$3.0B	$2.9B	$2.8B	$2.4B	$2.8B	$2.4B	$2.0B	$1.1B	$1.2B	$1.0B	$1.1B	$965M	$887M
Earnings Per Share (EPS)	$7.45	$7.28	$7.37	$4.79	$3.81	$3.91	$-4.20	$5.33	$4.88	$5.12	$4.14	$3.32	$3.93	$3.16	$2.35	$1.91	$2.23	$1.74	$1.80	$1.70	$1.43
Shares Outstanding (M)	283M	285M	287M	286M	287M	289M	287M	292M	293M	294M	297M	301M	306M	306M	299M	242M	238M	240M	249M	252M	257M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ECL Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$4.4B	$4.1B	$4.2B	$4.2B	$4.0B	$3.7B	$4.0B	$4.0B
Gross Profit	$1.9B	$1.8B	$1.8B	$1.9B	$1.8B	$1.6B	$1.7B	$1.7B
Gross Margin %	44.1%	43.5%	44.0%	44.8%	44.8%	44.3%	43.4%	43.4%
Operating Income (EBIT)	$758M	$622M	$786M	$760M	$710M	$587M	$686M	$707M
Operating Margin %	17.2%	15.3%	18.7%	18.2%	17.6%	15.9%	17.1%	17.7%
Net Income	$535M	$433M	$564M	$585M	$524M	$402M	$473M	$736M
Net Margin %	12.1%	10.6%	13.4%	14.1%	13.0%	10.9%	11.8%	18.4%
EBITDA	$767M	$876M	$903M	$789M	$978M	$818M	$848M	$1.3B
Earnings Per Share (EPS)	$1.89	$1.52	$1.98	$2.05	$1.84	$1.41	$1.66	$2.58
Shares Outstanding (M)	283M	284M	284M	285M	285M	285M	286M	286M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ECL Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$3.1B	$3.0B	$2.8B	$2.4B	$1.8B	$2.1B	$1.9B	$2.4B	$2.3B	$2.1B	$1.9B	$2.0B	$1.8B	$1.6B	$1.2B	$686M	$950M	$695M	$753M	$798M	$628M
Capital Expenditures (CapEx)	$1.2B	$1.0B	$994M	$775M	$713M	$643M	$489M	$731M	$847M	$869M	$757M	$815M	$794M	$662M	$608M	$366M	$298M	$297M	$394M	$362M	$321M
Free Cash Flow (FCF)	$1.9B	$1.9B	$1.8B	$1.6B	$1.1B	$1.4B	$1.4B	$1.7B	$1.4B	$1.2B	$1.2B	$1.2B	$1.0B	$898M	$596M	$320M	$653M	$398M	$359M	$436M	$307M
FCF Margin %	11.1%	11.8%	11.6%	10.7%	7.6%	11.1%	11.6%	13.5%	9.8%	8.8%	9.0%	8.8%	7.1%	6.8%	5.0%	4.7%	10.7%	6.7%	5.8%	8.0%	6.3%
Dividends Paid	$798M	$754M	$664M	$617M	$603M	$566M	$561M	$553M	$496M	$449M	$428M	$401M	$344M	$218M	$307M	$163M	$146M	$133M	$128M	$114M	$101M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ECL Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$730M	$446M	$1.1B	$791M	$702M	$369M	$767M	$787M
Capital Expenditures (CapEx)	$240M	$348M	$332M	$262M	$217M	$238M	$360M	$236M
Free Cash Flow (FCF)	$489M	$97M	$758M	$530M	$485M	$132M	$407M	$550M
FCF Margin %	11.1%	2.4%	18.1%	12.7%	12.0%	3.6%	10.2%	13.8%
Dividends Paid	$208M	$216M	$189M	$184M	$188M	$192M	$161M	$162M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ECL Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$29.9B	$24.7B	$22.4B	$21.8B	$21.5B	$21.2B	$18.1B	$20.9B	$20.1B	$20.0B	$18.3B	$18.6B	$19.5B	$19.6B	$17.6B	$18.2B	$4.9B	$5.0B	$4.8B	$4.7B	$4.4B
Cash & Cash Equivalents	$5.1B	$646M	$1.3B	$920M	$599M	$360M	$1.3B	$119M	$115M	$211M	$327M	$93M	$210M	$339M	$1.2B	$1.8B	$242M	$74M	$67M	$137M	$484M
Total Liabilities	$19.8B	$14.9B	$13.6B	$13.8B	$14.2B	$14.0B	$11.9B	$12.1B	$12.0B	$12.3B	$11.4B	$11.7B	$12.1B	$12.2B	$11.4B	$12.5B	$2.7B	$3.0B	$3.2B	$2.8B	$2.7B
Total Debt (Short + Long-Term)	$13.2B	$8.2B	$7.7B	$8.3B	$8.7B	$8.9B	$6.8B	$6.5B	$7.0B	$7.3B	$6.7B	$6.5B	$6.6B	$6.9B	$6.5B	$7.6B	$846M	$967M	$1.1B	$1.0B	$1.1B
Total Shareholders' Equity	$10.1B	$9.8B	$8.8B	$8.0B	$7.2B	$7.2B	$6.2B	$8.7B	$8.0B	$7.6B	$6.9B	$6.9B	$7.3B	$7.3B	$6.1B	$5.7B	$2.1B	$2.0B	$1.6B	$1.9B	$1.7B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ECL viewer.

ECL Metric Deep Dives

Other Companies in Specialty Chemicals

4187 · Osaka Organic Chemical Industry Ltd. — JPY 83 billion
KINGFA · Kingfa Science & Technology (India) Limited — ₹79 billion
GALAXYSURF · Galaxy Surfactants Limited — ₹79 billion
SHW · Sherwin-Williams — $78 billion
NEOGEN · Neogen Chemicals Limited — ₹75 billion
4022 · Rasa Industries, Ltd. — JPY 72 billion
4365 · Matsumoto Yushi-Seiyaku Co., Ltd. — JPY 71 billion
BALAMINES · Balaji Amines Limited — ₹70 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← ECK All “E” companies ECLERX →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.